# DOTAREM®-Enhanced MRA Compared to GADOVIST®-Enhanced MRA in Patients With Abdominal or Lower Limb Arterial Diseases

> **NCT00955617** · PHASE4 · COMPLETED · sponsor: **Guerbet** · enrollment: 20 (actual)

## Conditions studied

- Peripheral Arterial Disease

## Interventions

- **OTHER:** Contrast-enhanced MRA - Imaging examination

## Key facts

- **NCT ID:** NCT00955617
- **Lead sponsor:** Guerbet
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-07
- **Primary completion:** 2010-06
- **Final completion:** 2010-10
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2012-11-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00955617

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00955617, "DOTAREM®-Enhanced MRA Compared to GADOVIST®-Enhanced MRA in Patients With Abdominal or Lower Limb Arterial Diseases". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00955617. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*